EP0537524A1
(en)
|
1991-10-17 |
1993-04-21 |
Shipley Company Inc. |
Radiation sensitive compositions and methods
|
GB9316895D0
(en)
|
1993-08-13 |
1993-09-29 |
Guy S And St Thomas Hospitals |
Hepatoselective insulin analogues
|
US6869930B1
(en)
*
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
US5631347A
(en)
*
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
US20010041786A1
(en)
*
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
US6417326B1
(en)
*
|
1996-04-11 |
2002-07-09 |
The University Of British Columbia |
Fusogenic liposomes
|
US5948751A
(en)
*
|
1996-06-20 |
1999-09-07 |
Novo Nordisk A/S |
X14-mannitol
|
AU3255297A
(en)
*
|
1996-07-11 |
1998-02-09 |
Novo Nordisk A/S |
Selective acylation method
|
US5905140A
(en)
*
|
1996-07-11 |
1999-05-18 |
Novo Nordisk A/S, Novo Alle |
Selective acylation method
|
ATE417622T1
(de)
|
1996-08-08 |
2009-01-15 |
Amylin Pharmaceuticals Inc |
Regulation gastrointestinaler beweglichkeit
|
UA65549C2
(uk)
*
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
US6310038B1
(en)
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
US6444641B1
(en)
|
1997-10-24 |
2002-09-03 |
Eli Lilly Company |
Fatty acid-acylated insulin analogs
|
IL134901A0
(en)
*
|
1997-10-24 |
2001-05-20 |
Lilly Co Eli |
Insoluble insulin compositions
|
ZA989744B
(en)
*
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
US6933272B1
(en)
|
1998-09-22 |
2005-08-23 |
Erik Helmerhorst |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
US6159931A
(en)
*
|
1998-09-29 |
2000-12-12 |
The Ohio State University |
Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells
|
AU4904800A
(en)
*
|
1999-05-27 |
2000-12-18 |
Robert Z-T. Luo |
Identification of compounds for modulating dimeric receptors
|
US6309633B1
(en)
*
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
IL149085A0
(en)
*
|
1999-10-29 |
2002-11-10 |
Inhale Therapeutic Syst |
A dry powder composition containing a di or tripeptide
|
KR20030005204A
(ko)
*
|
2000-12-25 |
2003-01-17 |
가부시키가이샤 시세이도 |
교감신경 활성화 향료 조성물
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US7905230B2
(en)
*
|
2001-05-09 |
2011-03-15 |
Novartis Ag |
Metered dose inhaler with lockout
|
US6828305B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
EP1397173A1
(en)
*
|
2001-06-20 |
2004-03-17 |
Nektar Therapeutics |
Powder aerosolization apparatus and method
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
US7166571B2
(en)
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6913903B2
(en)
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US6770625B2
(en)
*
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
KR101009309B1
(ko)
*
|
2001-10-18 |
2011-01-18 |
넥타르 테라퓨틱스 |
아편양 길항제의 중합체 공액
|
WO2003057593A1
(en)
|
2001-12-21 |
2003-07-17 |
Nektar Therapeutics |
Capsule package with moisture barrier
|
JP2005514273A
(ja)
*
|
2001-12-21 |
2005-05-19 |
ネクター セラピューティクス |
包装における医薬製剤の密封
|
ES2360182T3
(es)
|
2002-05-07 |
2011-06-01 |
Novo Nordisk A/S |
Formulaciones solubles que comprenden insulina monomérica e insulina acilada.
|
US6941980B2
(en)
*
|
2002-06-27 |
2005-09-13 |
Nektar Therapeutics |
Apparatus and method for filling a receptacle with powder
|
EP1579004B1
(en)
*
|
2002-10-23 |
2010-06-16 |
VIRxSYS Corporation |
Screening methods for identification of efficient pre-trans-splicing molecules
|
US7516741B2
(en)
*
|
2002-12-06 |
2009-04-14 |
Novartis Ag |
Aerosolization apparatus with feedback mechanism
|
US20040206350A1
(en)
*
|
2002-12-19 |
2004-10-21 |
Nektar Therapeutics |
Aerosolization apparatus with non-circular aerosolization chamber
|
CA2508870C
(en)
|
2002-12-30 |
2012-10-16 |
Nektar Therapeutics |
Prefilming atomizer
|
US20050236296A1
(en)
*
|
2002-12-30 |
2005-10-27 |
Nektar Therapeutics (Formerly Inhale Therapeutic Systems, Inc.) |
Carry case for aerosolization apparatus
|
US7669596B2
(en)
*
|
2002-12-31 |
2010-03-02 |
Novartis Pharma Ag |
Aerosolization apparatus with rotating capsule
|
EP1581260B1
(en)
|
2002-12-31 |
2014-09-17 |
Nektar Therapeutics |
Polymeric reagents comprising a ketone or a related functional group
|
SI1610850T2
(sl)
*
|
2003-04-09 |
2020-11-30 |
Novartis Ag |
Naprava za aerosolizacijo s ščitom za vstopni zrak
|
HUE026950T2
(en)
|
2003-04-09 |
2016-08-29 |
Novartis Ag |
Nozzle with guide wire for puncturing the capsule
|
US8869794B1
(en)
|
2003-04-09 |
2014-10-28 |
Novartis Pharma Ag |
Aerosolization apparatus with capsule puncturing member
|
EP1626741A2
(en)
|
2003-05-23 |
2006-02-22 |
Nektar Therapeutics Al, Corporation |
Peg derivatives having an amidocarbonate linkage
|
WO2005012346A1
(en)
*
|
2003-07-25 |
2005-02-10 |
Conjuchem, Inc. |
Long lasting insulin derivatives and methods thereof
|
LT1675622T
(lt)
|
2003-09-17 |
2017-09-11 |
Nektar Therapeutics |
Daugiašakio polimero provaistai
|
WO2005044226A2
(en)
*
|
2003-11-04 |
2005-05-19 |
Nectar Therapeutics |
Lipid formulations for spontaneous drug encapsulation
|
US20050214250A1
(en)
|
2003-11-06 |
2005-09-29 |
Harris J M |
Method of preparing carboxylic acid functionalized polymers
|
JP2007532096A
(ja)
|
2003-11-14 |
2007-11-15 |
ノボ ノルディスク アクティーゼルスカブ |
アシル化されたインスリンの製造方法
|
AU2004297228A1
(en)
|
2003-12-03 |
2005-06-23 |
Nektar Therapeutics Al, Corporation |
Method of preparing maleimide functionalized polymers
|
US20060182692A1
(en)
|
2003-12-16 |
2006-08-17 |
Fishburn C S |
Chemically modified small molecules
|
SI1694363T1
(sl)
*
|
2003-12-16 |
2014-03-31 |
Nektar Therapeutics |
Monodisperzni PEG-ilirani naloksolni sestavki
|
WO2005067898A2
(en)
*
|
2004-01-07 |
2005-07-28 |
Nektar Therapeutics |
Improved sustained release compositions for pulmonary administration of insulin
|
US8562965B2
(en)
*
|
2004-05-03 |
2013-10-22 |
Nektar Therapeutics |
Polymer derivatives comprising an acetal or ketal branching point
|
US9085659B2
(en)
*
|
2004-05-03 |
2015-07-21 |
Nektar Therapeutics |
Polymer derivatives comprising an imide branching point
|
WO2006005667A2
(en)
|
2004-07-08 |
2006-01-19 |
Novo Nordisk A/S |
Polypeptide protracting tags comprising a tetrazole moiety
|
US7872095B2
(en)
|
2004-07-19 |
2011-01-18 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
KR20070085227A
(ko)
*
|
2004-08-09 |
2007-08-27 |
앨리오스 바이오파마 인크. |
합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
EP2292653B1
(en)
*
|
2005-02-02 |
2014-05-21 |
Novo Nordisk A/S |
Novel insulin derivatives
|
AU2006287934B2
(en)
*
|
2005-05-18 |
2012-12-13 |
Nektar Therapeutics |
Valves, devices, and methods for endobronchial therapy
|
JP5600240B2
(ja)
*
|
2005-07-19 |
2014-10-01 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
重合体マレイミド類を調製する方法
|
KR101354244B1
(ko)
|
2005-07-29 |
2014-02-18 |
넥타르 테라퓨틱스 |
폴리(에틸렌 글리콜) 의 카르보네이트 에스테르를 제조하는방법
|
US9056921B2
(en)
|
2005-08-16 |
2015-06-16 |
Novo Nordisk A/S |
Method for making mature insulin polypeptides
|
EP1928525A2
(en)
*
|
2005-09-29 |
2008-06-11 |
Nektar Therapeutics |
Receptacles and kits, such as for dry powder packaging
|
JP2009510077A
(ja)
|
2005-09-29 |
2009-03-12 |
ネクター セラピューティックス |
抗生物質製剤、単位用量、キットおよび方法
|
CN101389650B
(zh)
|
2005-12-28 |
2012-10-10 |
诺沃-诺迪斯克有限公司 |
包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
|
JP5242415B2
(ja)
*
|
2006-01-18 |
2013-07-24 |
フォアシーエイサー ファーマシューティカルズ インコーポレイテッド |
高い安定性を持つ薬理組成物
|
US8927015B2
(en)
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
WO2007128817A2
(en)
*
|
2006-05-09 |
2007-11-15 |
Novo Nordisk A/S |
Insulin derivative
|
WO2008008363A1
(en)
*
|
2006-07-11 |
2008-01-17 |
Qps, Llc |
Pharmaceutical compositions for sustained release delivery of peptides
|
WO2008015099A2
(en)
|
2006-07-31 |
2008-02-07 |
Novo Nordisk A/S |
Pegylated, extended insulins
|
CN101541830A
(zh)
|
2006-09-22 |
2009-09-23 |
诺沃-诺迪斯克有限公司 |
蛋白酶抗性的胰岛素类似物
|
WO2008037735A1
(en)
|
2006-09-27 |
2008-04-03 |
Novo Nordisk A/S |
Method for making maturated insulin polypeptides
|
ES2596263T3
(es)
*
|
2006-10-25 |
2017-01-05 |
Novartis Ag |
Aparato de dispersión de polvo
|
DK2120875T3
(en)
|
2007-02-11 |
2018-10-22 |
Map Pharmaceuticals Inc |
METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO POSSIBLE QUICK PREVENTION OF MIGRANE AT THE MINIMUM OF THE SIDE EFFECT PROFILE
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
EP2152245B1
(en)
|
2007-04-30 |
2015-12-02 |
Novo Nordisk A/S |
Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
|
EP2164459A1
(en)
*
|
2007-06-01 |
2010-03-24 |
Novo Nordisk A/S |
Stable non-aqueous pharmaceutical compositions
|
ES2744384T3
(es)
|
2007-06-13 |
2020-02-24 |
Novo Nordisk As |
Formulación farmacéutica que comprende un derivado de insulina
|
EP2708554A1
(en)
|
2007-08-15 |
2014-03-19 |
Novo Nordisk A/S |
Insulin analogues with an acyl and alkylene glycol moiety
|
KR101234540B1
(ko)
|
2007-10-16 |
2013-02-19 |
바이오콘 리미티드 |
경구 투여가능한 고형 약제학적 조성물 및 그 제조방법
|
KR20100098610A
(ko)
*
|
2007-10-25 |
2010-09-08 |
노파르티스 아게 |
단위 투여량의 약물 포장물의 분말 컨디셔닝
|
JP5762001B2
(ja)
|
2008-03-14 |
2015-08-12 |
ノボ・ノルデイスク・エー/エス |
プロテアーゼ安定化インスリンアナログ
|
US8691759B2
(en)
|
2008-03-18 |
2014-04-08 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
RS53238B
(en)
|
2008-04-04 |
2014-08-29 |
Nektar Therapeutics |
AEROSOLIZATION DEVICE
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
WO2010014258A2
(en)
*
|
2008-08-01 |
2010-02-04 |
Nektar Therapeutics Al, Corporation |
Conjugates having a releasable linkage
|
MX2011001583A
(es)
|
2008-08-11 |
2011-04-04 |
Nektar Therapeutics |
Conjugados de alcanoato polimericos de multiples brazos.
|
CN102209541B
(zh)
|
2008-09-08 |
2016-05-18 |
小利兰·斯坦福大学托管委员会 |
醛脱氢酶活性调节剂和其使用方法
|
WO2010030366A2
(en)
|
2008-09-11 |
2010-03-18 |
Nektar Therapeutics |
Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
|
EP2341942A1
(en)
*
|
2008-09-19 |
2011-07-13 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
KR20110082180A
(ko)
|
2008-10-28 |
2011-07-18 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
알데히드 탈수소효소의 조절자 및 그것의 사용방법
|
BRPI0919946A2
(pt)
|
2008-10-30 |
2016-02-16 |
Novo Nordisk As |
tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
|
CA2750252A1
(en)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Synthetic conjugates and uses thereof
|
BRPI1007466A2
(pt)
|
2009-01-28 |
2018-06-12 |
Smartcells Inc |
conjugado de insulina cristalina, formulação de liberação prolongada, e, sistema de distribuição de bomba
|
JP2012516339A
(ja)
|
2009-01-28 |
2012-07-19 |
スマートセルズ・インコーポレイテツド |
外因的刺激型制御放出物質体およびその使用
|
SG2014006597A
(en)
|
2009-01-28 |
2014-04-28 |
Smartcells Inc |
Conjugate based systems for controlled drug delivery
|
CN102316892B
(zh)
|
2009-02-12 |
2014-06-04 |
西马生物医学计划公司 |
心肌营养素-1用于治疗代谢病的用途
|
PL2413902T3
(pl)
|
2009-03-18 |
2020-01-31 |
Incarda Therapeutics, Inc. |
Dawki jednostkowe, aerozole, zestawy oraz sposoby leczenia chorób serca przez podawanie dopłucne
|
EP2408470A4
(en)
|
2009-03-20 |
2012-08-29 |
Smartcells Inc |
SOLUBLE NONDEPOT INSULIN CONJUGATE AND ITS USE
|
JP2012520879A
(ja)
|
2009-03-20 |
2012-09-10 |
スマートセルズ・インコーポレイテツド |
末端官能基化コンジュゲートおよびその用途
|
EP2453962B1
(en)
|
2009-07-17 |
2018-03-14 |
Nektar Therapeutics |
Negatively biased sealed nebulizers systems and methods
|
JP5892940B2
(ja)
|
2009-11-25 |
2016-03-23 |
アリスジェン ソシエテ アノニム |
クラウン化合物及び/又は対イオンと複合体化されたペプチドを含む粘膜送達組成物
|
CA2787353A1
(en)
|
2010-01-19 |
2011-07-28 |
Nektar Therapeutics |
Identifying dry nebulizer elements
|
WO2012015681A2
(en)
|
2010-07-28 |
2012-02-02 |
Smartcells, Inc. |
Drug-ligand conjugates, synthesis thereof, and intermediates thereto
|
US9068013B2
(en)
|
2010-07-28 |
2015-06-30 |
Smart Cells, Inc. |
Recombinant lectins, binding-site modified lectins and uses thereof
|
US9074015B2
(en)
|
2010-07-28 |
2015-07-07 |
Smartcells, Inc. |
Recombinantly expressed insulin polypeptides and uses thereof
|
DK2632478T3
(da)
|
2010-10-27 |
2019-10-07 |
Novo Nordisk As |
Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
|
US10894087B2
(en)
|
2010-12-22 |
2021-01-19 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
WO2012088422A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US20140088021A1
(en)
|
2011-05-27 |
2014-03-27 |
Nektar Therapeutics |
Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
|
EP2790761B1
(en)
|
2011-12-16 |
2022-05-11 |
Novartis AG |
Passive powder aerosolization apparatus
|
BR112014025132A2
(pt)
|
2012-04-11 |
2017-07-11 |
Novo Nordisk As |
formulações de insulina
|
EA033469B1
(ru)
|
2012-04-16 |
2019-10-31 |
Cantab Biopharmaceuticals Patents Ltd |
Подкожное введение конъюгатов факторов крови с полиэтиленгликолем
|
JP6735561B2
(ja)
|
2012-12-03 |
2020-08-05 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
O−グリコシル化カルボキシ末端部分(ctp)ペプチド系のインスリンおよびインスリン類似体
|
CN105358531B
(zh)
|
2013-03-14 |
2017-11-14 |
利兰-斯坦福大学初级学院的董事会 |
线粒体醛脱氢酶‑2调节剂和其使用方法
|
US10137172B2
(en)
|
2013-04-30 |
2018-11-27 |
Novo Nordisk A/S |
Administration regime
|
AR097893A1
(es)
|
2013-10-04 |
2016-04-20 |
Merck Sharp & Dohme |
Conjugados de insulina sensibles a glucosa
|
BR112016007166A2
(pt)
|
2013-10-07 |
2017-09-12 |
Novo Nordisk As |
derivado de um análogo de insulina
|
AR099569A1
(es)
|
2014-02-28 |
2016-08-03 |
Novo Nordisk As |
Derivados de insulina y los usos médicos de estos
|
US9656017B2
(en)
|
2014-06-20 |
2017-05-23 |
Howard E. Greene |
Infusion delivery devices and methods
|
WO2017127420A1
(en)
|
2016-01-19 |
2017-07-27 |
Nektar Therapeutics |
Sealed liquid reservoir for a nebulizer
|
GB2581301A
(en)
|
2016-02-01 |
2020-08-12 |
Incarda Therapeutics Inc |
Combining electronic monitoring with inhaled pharmacological therapy to manage atrial arrhythmias including atrial fibrillation
|
JP6690062B2
(ja)
|
2016-12-16 |
2020-04-28 |
ノヴォ ノルディスク アー/エス |
インスリン含有医薬組成物
|
CN110869018A
(zh)
|
2017-05-10 |
2020-03-06 |
英凯达治疗公司 |
通过肺部施用治疗心脏病况的单位剂量、气雾剂、试剂盒和方法
|
PE20211264A1
(es)
|
2017-08-17 |
2021-07-15 |
Novo Nordisk As |
Analogos de insulina acilados novedosos y usos de estos
|
WO2019125879A2
(en)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Conjugate based systems for controlled insulin delivery
|
WO2019125878A1
(en)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Conjugate based systems for controlled insulin delivery
|
US10744087B2
(en)
|
2018-03-22 |
2020-08-18 |
Incarda Therapeutics, Inc. |
Method to slow ventricular rate
|
US10335464B1
(en)
|
2018-06-26 |
2019-07-02 |
Novo Nordisk A/S |
Device for titrating basal insulin
|
US20220296521A1
(en)
|
2019-06-10 |
2022-09-22 |
Respira Therapeutics, Inc. |
Carrier-based formulations and related methods
|
US11007185B2
(en)
|
2019-08-01 |
2021-05-18 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
AU2021247169A1
(en)
|
2020-03-31 |
2022-10-20 |
Protomer Technologies Inc. |
Conjugates for selective responsiveness to vicinal diols
|
WO2021231676A1
(en)
*
|
2020-05-15 |
2021-11-18 |
Eli Lilly And Company |
Extended time action acylated insulin compounds
|
AU2021382599A1
(en)
|
2020-11-19 |
2023-06-22 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and insulin analogs
|
WO2023225534A1
(en)
|
2022-05-18 |
2023-11-23 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|